Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.
We estimated the unit costs and cost-effectiveness of a government ART program in 45 sites in Zambia supported by the Centre for Infectious Disease Research Zambia (CIDRZ).We estimated per person-year costs at the facility level, and support costs incurred above the facility level and used multiple...
Main Authors: | Elliot Marseille, Mark J Giganti, Albert Mwango, Angela Chisembele-Taylor, Lloyd Mulenga, Mead Over, James G Kahn, Jeffrey S A Stringer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3527397?pdf=render |
Similar Items
-
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.
by: Gesine Meyer-Rath, et al.
Published: (2012-01-01) -
Avahan and the cost-effectiveness of “prevention as prevention”
by: Elliot Marseille, et al.
Published: (2014-09-01) -
Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health
by: Elliot Marseille, et al.
Published: (2019-04-01) -
Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia
by: Shinsuke Miyano, et al.
Published: (2017-04-01) -
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
by: Franziska Schöni-Affolter, et al.
Published: (2011-01-01)